SCHEMBL16811801

SCHEMBL16811801

Cc1c(C(=O)NC2CCN(Cc3ccc(N4CCC(NC(=O)c5ccccc5)CC4)nc3)CC2)cccc1-c1cccnc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMO Q99835 1/20 0.73
▸ DRD4 P21917 2/20 0.49
▸ CXCR4 P61073 1/20 0.49
▸ SLC6A5 Q9Y345 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ CKS1B P61024 1/20 0.46
▸ SKP1 P63208 1/20 0.46
▸ SKP2 Q13309 1/20 0.46
▸ CD274 Q9NZQ7 1/20 0.45
▸ SIGMAR1 Q99720 1/20 0.45
▸ MCHR1 Q99705 1/20 0.45
▸ CCR3 P51677 1/20 0.45
▸ WNT1 P04628 1/20 0.45
▸ DYRK1A Q13627 1/20 0.45
▸ SSTR5 P35346 1/20 0.45
▸ PRKAB2 O43741 1/20 0.45
▸ PRKAG1 P54619 1/20 0.45
▸ PRKAA2 P54646 1/20 0.45
▸ PRKAA1 Q13131 1/20 0.45
▸ PRKAG3 Q9UGI9 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16811878 0.95 SMO (0.72) SMODRD4CXCR4SLC6A5POLB
SCHEMBL16811859 0.94 SMO (0.84) SMODRD4CXCR4SLC6A5MCHR1
SCHEMBL16811873 0.94 SMO (0.84) SMODRD4CXCR4SLC6A5MCHR1
SCHEMBL16811843 0.93 SMO (0.62) SMODRD4CXCR4SLC6A5POLB
SCHEMBL16811782 0.92 SMO (0.68) SMODRD4CXCR4SLC6A5POLB
SCHEMBL16811805 0.92 SMO (0.61) SMODRD4POLBCKS1BSKP1
SCHEMBL16811913 0.91 SMO (0.66) SMODRD4CXCR4SLC6A5POLB
SCHEMBL15615023 0.91 SMO (0.66) SMODRD4CXCR4SLC6A5POLB
SCHEMBL16812013 0.91 SMO (0.79) SMODRD4CXCR4SLC6A5CD274
SCHEMBL16811981 0.91 SMO (0.79) SMODRD4CXCR4SLC6A5CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-9512106-B2 Smoothened modulators and methods of use thereof DUKE UNIVERSITY (US) 2016-12-06 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF UNIV DUKE (US) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166509-A1 SMOOTHENED MODULATORS AND METHODS OF USE THEREOF SMO, SHH, GLI1 SMO 1/4885DRD4 4828/4885CXCR4 3485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback